Price transparency compliance and variation for proton therapy in the United States

Cancer Letters 2026 Open access

Read full text
Authors: Kasey R. Cargill, Noah Maxwell Feder, Tyler J. Wilhite, Walid F. Gellad, Heath Devin Skinner, Yvonne Marie Mowery, Christopher T. Wilke
DOI: 10.1016/j.canlet.2026.218260
Cited by: 0
References: 11

Abstract

• CMS mandates hospitals to disclose detailed pricing in a consumer-friendly format • Only 30% of hospitals were fully CMS price transparency compliant • PPS-exempt centers had similar compliance rates to non-exempt hospitals • Most hospitals failed to report payor-negotiated rates as required • Price transparency remains limited despite federal mandates and penalties

Fields of Study & Subjects

Healthcare Policy and Management Healthcare Law Governance and Management Studies Pharmaceutical Economics and Policy

Publication details

Journal / source
Cancer Letters
Volume
640
Pages
218260–218260
Publication date
17 January 2026
Language
EN